Effects of salmeterol and fluticasone propionate combined montelukast in the treatment of patients with bronchial asthma
10.7501/j.issn.1674-6376.2017.06.20
- VernacularTitle:孟鲁司特钠联合沙美特罗氟替卡松治疗支气管哮喘患者的疗效观察
- Author:
Haiying LU
;
Quan YUAN
;
Xiaodong YANG
;
Xiaobing WAN
;
Bin LI
- Keywords:
salmeterol and fluticasone propionate;
montelukast;
asthma;
pulmonary function
- From:
Drug Evaluation Research
2017;40(6):828-831
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effects of salmeterol and fluticasone propionate combined montelukastin the treatment of patients with bronchial asthma.Methods Ninety-eight bronchial asthma patients from April 2014 to March 2016 in the Fourth People's Hospital Sichuan Province were selected anddivided into observation group and control group with 49 patients in each group according to the above principles by prospective study.The control group was given salmeterol treatment,and the observation group was added given montelukast treatment based on the control group.The treatment days were 15 d recorded the prognosis of the two groups.Results The total effective rates of the observation group and the control group were 95.9％ and 81.6％ respectively,the total effective rate of the observation group was significantly higher than that of the control group (P ＜ 0.05).The FEV1 and FVC values after treatment in the observation group and control group were significantly higher than before treatment (P ＜ 0.05),while the FEV1 and FVC values in the observation group after treatment were significantly higher than those in the control group (P ＜ 0.05).The scores of ACT scale after treatment of two groups were obviously higher than before treatment,and the score of observation group was statistically higher than control group after treatment (P ＜ 0.05).During treatment,there was no statistical significance on adverse reaction between two groups.Conclusion Salmeterol and fluticasone propionate combined montelukast in the treatment of patients with bronchial asthma can promote the improvement of lung function,so as to improve the quality of life and clinical treatment.
